ES2177646T3 - Procedimientos para el tratamiento de los trastornos hemorragicos. - Google Patents
Procedimientos para el tratamiento de los trastornos hemorragicos.Info
- Publication number
- ES2177646T3 ES2177646T3 ES95917218T ES95917218T ES2177646T3 ES 2177646 T3 ES2177646 T3 ES 2177646T3 ES 95917218 T ES95917218 T ES 95917218T ES 95917218 T ES95917218 T ES 95917218T ES 2177646 T3 ES2177646 T3 ES 2177646T3
- Authority
- ES
- Spain
- Prior art keywords
- disorders
- treating
- vwd
- hemorragical
- procedures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2073—IL-11
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Soy Sauces And Products Related Thereto (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN METODO PARA TRATAR LA ENFERMEDAD DE WILLEBRAND (WWD) MEDIANTE LA ADMINISTRACION DE UNA CITOQUINA, COMO IL-11, IL-6, LIF, OSM, O CNTF. LA PRESENTE INVENCION SE REFIERE GENERALMENTE A NUEVOS METODOS PARA TRATAR TRASTORNOS SANGUINEOS Y MAS ESPECIFICAMENTE SE REFIERE A METODOS PARA TRATAR LA HEMOFILIA A DE LA ENFERMEDAD DE WILLEBRAND (VWD), Y VARIOS TRASTORNOS HEMOSTATICOS COMO LA UREMIA, LA CIRROSIS, DEFECTOS PLAQUETARIOS CONGENITOS, Y DEFICIENCIAS EN EL EQUIPO DE ALMACENAMIENTO ADQUIRIDO Y CONGENITO, PACIENTES CON DILACIONES INEXPLICABLES DE TIEMPO DE COAGULACION, ASI COMO EN EL TRATAMIENTO PROFILACTICO ANTES DE LA CIRUGIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/278,765 US5582821A (en) | 1994-07-22 | 1994-07-22 | Methods for treating bleeding disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2177646T3 true ES2177646T3 (es) | 2002-12-16 |
Family
ID=23066267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95917218T Expired - Lifetime ES2177646T3 (es) | 1994-07-22 | 1995-04-27 | Procedimientos para el tratamiento de los trastornos hemorragicos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5582821A (es) |
EP (1) | EP0772450B1 (es) |
JP (1) | JPH10503195A (es) |
AT (1) | ATE219372T1 (es) |
AU (1) | AU2381795A (es) |
DE (1) | DE69527145T2 (es) |
DK (1) | DK0772450T3 (es) |
ES (1) | ES2177646T3 (es) |
PT (1) | PT772450E (es) |
WO (1) | WO1996003143A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO439396A0 (en) * | 1996-12-24 | 1997-01-23 | Walter And Eliza Hall Institute Of Medical Research, The | A method of treatment and prophylaxis |
US6953777B2 (en) | 1999-03-11 | 2005-10-11 | Genetics Indtitute LLC | Use of interleukin-11 to prevent immune-mediated cytotoxicity |
PL360914A1 (en) * | 1999-07-15 | 2004-09-20 | Genetics Institute Inc. | Formulations for il-11 |
AU2002362088A1 (en) * | 2001-12-06 | 2003-06-23 | Catholic University | Method and composition for inducing weight loss |
US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
CA2835434A1 (en) | 2011-05-17 | 2012-11-22 | Velico Medical, Inc. | Improved platelet storage using a sialidase inhibitor |
US9609861B2 (en) | 2011-05-17 | 2017-04-04 | Velico Medical Inc. | Platelet additive solution having a β-galactosidase inhibitor |
WO2014120886A1 (en) | 2013-01-30 | 2014-08-07 | Velico Medical, Inc. | Platelet additive solution having a self-assembling hydrogel-forming peptide |
US20150160214A1 (en) * | 2013-12-05 | 2015-06-11 | Mayo Foundation For Medical Education And Research | Quantitation of Cellular Adhesion Dynamics Across Immobilized Receptors Under Rheological Shear Flow |
CN117157317A (zh) | 2021-02-26 | 2023-12-01 | 拜耳公司 | 用于治疗异常子宫出血的IL-11或IL-11Ra的抑制剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US5215895A (en) * | 1989-11-22 | 1993-06-01 | Genetics Institute, Inc. | Dna encoding a mammalian cytokine, interleukin-11 |
ES2118756T5 (es) * | 1990-08-29 | 2004-01-16 | Genetics Institute, Llc | Estimuladores de hematopoyesis de multiples dominios. |
US5292646A (en) * | 1991-02-06 | 1994-03-08 | Genetics Institute, Inc. | Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
US5270181A (en) * | 1991-02-06 | 1993-12-14 | Genetics Institute, Inc. | Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
WO1993006840A1 (fr) * | 1991-10-09 | 1993-04-15 | Toray Industries, Inc. | Medicament de prevention et de traitement de la tendance a l'hemorragie |
-
1994
- 1994-07-22 US US08/278,765 patent/US5582821A/en not_active Expired - Lifetime
-
1995
- 1995-04-27 ES ES95917218T patent/ES2177646T3/es not_active Expired - Lifetime
- 1995-04-27 DK DK95917218T patent/DK0772450T3/da active
- 1995-04-27 WO PCT/US1995/005439 patent/WO1996003143A1/en active IP Right Grant
- 1995-04-27 EP EP95917218A patent/EP0772450B1/en not_active Expired - Lifetime
- 1995-04-27 AT AT95917218T patent/ATE219372T1/de not_active IP Right Cessation
- 1995-04-27 JP JP8505717A patent/JPH10503195A/ja active Pending
- 1995-04-27 AU AU23817/95A patent/AU2381795A/en not_active Abandoned
- 1995-04-27 PT PT95917218T patent/PT772450E/pt unknown
- 1995-04-27 DE DE69527145T patent/DE69527145T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE219372T1 (de) | 2002-07-15 |
JPH10503195A (ja) | 1998-03-24 |
DE69527145T2 (de) | 2003-02-13 |
WO1996003143A1 (en) | 1996-02-08 |
DK0772450T3 (da) | 2003-04-14 |
US5582821A (en) | 1996-12-10 |
EP0772450B1 (en) | 2002-06-19 |
PT772450E (pt) | 2002-10-31 |
DE69527145D1 (de) | 2002-07-25 |
AU2381795A (en) | 1996-02-22 |
EP0772450A1 (en) | 1997-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2037664T3 (es) | Composiciones y metodos para el tratamiento de trastornos hemorragicos. | |
DE68919361D1 (de) | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. | |
ATE77557T1 (de) | Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. | |
DE59407237D1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
DE1300150T1 (de) | Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck | |
DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
BR9812228A (pt) | Esponja de fibrina, processo para a preparação da mesma, uso de uma esponja de fibrina, e, kit. | |
EA199800690A1 (ru) | Замещенные n-[(аминоиминометил)фенилалкил]азагетероцикламиды сульфоновых кислот | |
ATE88899T1 (de) | Wundheilung und knochenregeneration. | |
DK0719154T3 (da) | Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel | |
DE69106586D1 (de) | Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris. | |
ES2177646T3 (es) | Procedimientos para el tratamiento de los trastornos hemorragicos. | |
NO995843D0 (no) | Farmasöytisk preparat omfattende vWF-propeptid | |
UA45942A (uk) | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
ES2173858T3 (es) | Analogos de huperzina a. | |
BRPI0015939B8 (pt) | sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação | |
AT383123B (de) | Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat | |
DE69133077T2 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
PT684816E (pt) | Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas | |
EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
DE60042171D1 (de) | Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen | |
DE69729201T2 (de) | Sulfonfluoride zur behandlung von der alzheimerischen krankheit | |
Saunders | Evaluation of platelet-inhibiting drugs in models of atherosclerosis | |
DK563886A (da) | Terapeutisk komposition |